Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spyre Therapeutics (SYRE) Exchange Rate Effect (2020 - 2024)

Spyre Therapeutics' Exchange Rate Effect history spans 5 years, with the latest figure at -$15000.0 for Q4 2024.

  • For Q4 2024, Exchange Rate Effect fell 183.33% year-over-year to -$15000.0; the TTM value through Sep 2025 reached -$15000.0, down 150.0%, while the annual FY2024 figure was -$3000.0, 112.0% down from the prior year.
  • Exchange Rate Effect reached -$15000.0 in Q4 2024 per SYRE's latest filing, down from $16000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $47000.0 in Q4 2020 to a low of -$72000.0 in Q2 2022.
  • Average Exchange Rate Effect over 5 years is -$3250.0, with a median of $3500.0 recorded in 2021.
  • The largest YoY upside for Exchange Rate Effect was 1433.33% in 2022 against a maximum downside of 1900.0% in 2022.
  • A 5-year view of Exchange Rate Effect shows it stood at $47000.0 in 2020, then crashed by 93.62% to $3000.0 in 2021, then skyrocketed by 1433.33% to $46000.0 in 2022, then crashed by 60.87% to $18000.0 in 2023, then tumbled by 183.33% to -$15000.0 in 2024.
  • Per Business Quant, the three most recent readings for SYRE's Exchange Rate Effect are -$15000.0 (Q4 2024), $16000.0 (Q3 2024), and -$4000.0 (Q1 2024).